Close

Mr Kwabena Asare

Research Fellow

London School of Hygiene & Tropical Medicine
Keppel street
London
United Kingdom

Kwabena joined the Electronic Health Records group in the Department of Non-Communicable Epidemiology in April 2024 as a Research Fellow. His research interests include using routinely collected observational data with robust causal inferential approaches to estimate causal effects of interventions and exposures for public health decision making. He is currently working with Professor Charlotte Warren-Gash on a number of projects related to infections, brain health and frailty during old age, using UK electronic health data from the Clinical Practice Research Database (CPRD) and US Veterans Health Administration (VHA). He holds a PhD in Public Health from University of KwaZulu-Natal, Durban, South Africa. His PhD research focused on contributing evidence to inform targeted interventions and healthcare policy to improve STI care in limited resource and HIV endemic settings in Sub-Saharan Africa. The evidence generated from his PhD involved identfying important risk factors for STI transmission and determing the impact of point-of-care testing for promt STI care versus centralised laboratory-based testing in South Africa. 

Affiliations

Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health

Research

Research Area
Epidemiology
Electronic health records
Disease and Health Conditions
Non-communicable diseases
Mental health
HIV/AIDS
Sexually transmitted infections
Chronic diseases
Infectious diseases
Country
United Kingdom

Selected Publications

Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort study.
ASARE, K; Sookrajh, Y; Van der Molen, J; Khubone, T; Lewis, L; Lessells, RJ; Naidoo, K; Sosibo, P; Van Heerden, R; Garrett, N; Dorward, J;
2023
The Lancet Global health
Relationship between physical activity and behaviour challenges of adolescents in South Africa.
ASARE, K; Ntlantsana, V; Ranjit, K; Tomita, A; Paruk, S;
2023
The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa
Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa.
ASARE, K; Lewis, L; Van der Molen, J; Sookrajh, Y; Khubone, T; Moodley, P; Lessells, RJ; Naidoo, K; Sosibo, P; Garrett, N; Dorward, J;
2023
Open forum infectious diseases
Incidence of herpes simplex virus type 2 positivity among women living with human immunodeficiency virus in South Africa.
ASARE, K; Ngcapu, S; Osman, F; Mindel, A; Naicker, N; Khanyile, M; Karim, SS A; Tomita, A; Garrett, N;
2023
International journal of STD & AIDS
Clinical outcomes after viraemia among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy in South Africa
ASARE, K; Lewis, L; Van der Molen, J; Sookrajh, Y; Khubone, T; Moodley, P; Lessells, R; Naidoo, K; Sosibo, P; Garrett, N; Dorward, J;
2023
medRxiv
Clinical outcomes after the introduction of dolutegravir for second-line antiretroviral therapy in South Africa: a retrospective cohort study
ASARE, K; Sookrajh, Y; Van der Molen, J; Khubone, T; Lewis, L; Lessells, R; Naidoo, K; Sosibo, P; Van Heerden, R; Garrett, N; Dorward, J;
2023
medRxiv
Incidence, recurrence, and prevalence of bacterial vaginosis from acute to chronic HIV infection in a prospective cohort of women in South Africa.
ASARE, K; Ngcapu, S; Osman, F; Vandormael, A; Mindel, A; Naicker, N; Khanyile, M; S Abdool Karim, S; Tomita, A; Garrett, N;
2023
Annals of Epidemiology
Depression onset and its association with community HIV prevalence: A geospatial and panel analyses of nationally representative South African data, 2015–2017
ASARE, K; Tomita, A; Garrett, N; Slotow, R; Burns, JK; Tanser, F; Cuadros, DF;
2022
Journal of affective disorders reports
Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial.
ASARE, K; Andine, T; Naicker, N; Dorward, J; Singh, N; Spooner, E; Andriesen, J; Osman, F; Ngcapu, S; Vandormael, A; Mindel, A; Abdool Karim, SS; Bekker, L-G; Gray, G; Corey, L; Tomita, A; Garrett, N;
2022
Clinical Infectious Diseases
See more information